WebCORSAIR PHARMA, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 400 Oyster Point Blvd Ste 202 South San Francisco, CA 94080: Registered Agent: Houda Chadli: Filing Date: June 30, 2014: File Number: 3689874: Contact Us About The Company Profile For Corsair Pharma, Inc. WebCorsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. Our First Product … The Corsair Pharma Team is developing transformative solutions to improve the … Corsair Pharma, Inc. to Present at LifeSci Partners Annual Private Company …
Wilshire Pharmaceuticals - Welcome
WebJun 24, 2024 · South San Francisco, Calif., June 24, 2024 – Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced it will host a Key Opinion Leader (KOL) webinar to discuss the current treatment landscape for Pulmonary Arterial Hypertension (PAH) on Thursday, July 8th, at 10:30 a.m. ET. The … WebCorsair Pharma, Inc. is a development-stage pharmaceutical company focused on the development of innovative transdermal therapeutics. The company’s lead program … klipsch speakers and turntable
Corsair Pharma and United Therapeutics Enter into …
WebJan 3, 2024 · Corsair Pharma, Inc. is a development stage biotechnology company operating as a portfolio company of Velocity Pharmaceutical Development, LLC and is … WebCorsair Pharma, Inc. USA n/a Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. Corsair’s first product candidate is a prodrug of treprostinil delivered on a proprietary transdermal patch to treat pulmonary arterial hypertension (PAH ... WebJun 24, 2024 · Corsair Pharma, Inc. is a development stage biopharmaceutical company operating as a portfolio company of Velocity Pharmaceutical Development, LLC and is … klipsch speaker set with atmos speakers